Eloxx Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Arlington, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Eloxx Pharmaceuticals, Inc. has filed 1,349 SEC EDGAR filings since 27 Mar 1997

SEC filing history

Showing 26-50 of 916 matching filings.

Per page
25
Current page
2
4

4

Filing date
08 May 2026
Reporting date
19 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 May 2026
Reporting date
06 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 May 2026
Reporting date
19 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14C File 001-31326

DEF 14C

Filing date
08 May 2026
Reporting date
08 May 2026
Next action
Verify source filing
3

3 filing

Filing date
04 May 2026
Reporting date
28 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-56243

SCHEDULE 13G filing

Filing date
04 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-56243

SCHEDULE 13G filing

Filing date
01 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
01 May 2026
Reporting date
27 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14C File 001-31326

PRE 14C

Filing date
28 Apr 2026
Reporting date
28 Apr 2026
Next action
Verify source filing
DRS File 377-09153

DRS filing

Filing date
20 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 001-31326

NT 10-Q

Filing date
14 Aug 2025
Reporting date
30 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 001-31326

NT 10-Q

Filing date
15 May 2025
Reporting date
31 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 001-31326

NT 10-K

Filing date
01 Apr 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF ACTION

SEC STAFF ACTION filing

Filing date
21 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
28 Jan 2025
Reporting date
24 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
28 Jan 2025
Reporting date
24 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
28 Jan 2025
Reporting date
24 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
28 Jan 2025
Reporting date
24 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 001-31326

NT 10-Q

Filing date
19 Nov 2024
Reporting date
30 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
17 Oct 2024
Reporting date
16 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .